CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted ...
PRNewswire/ - CIOs are heading into 2026 under growing pressure to justify technology investment as AI initiatives scale and ...